| Date | Document Name | Document |
|---|---|---|
| 08-04-2026 | Encumbrance (Annual Disclosure) | |
| 08-04-2026 | Reconciliation of Share Capital Audit Report (Q4F26) | |
| 08-04-2026 | Compliance Certificate (RTA) 74(5) - (Q4F26) | |
| 08-04-2026 | Annual Confirmation (Reclassification) - F26 | |
| 03-04-2026 | Investor Complain (Q4F26) | |
| 30-03-2026 | Intimation of New Email ID & Website | |
| 30-03-2026 | Notice of Postal Ballot (March 31, 2026 – April 29, 2026) | |
| 26-03-2026 | Events Calendar (Postal Ballot) | |
| 20-03-2026 | Closure of Trading Window | |
| 28-02-2026 | Special Window (Physical Shares) | |
| 13-02-2026 | Newspaper Publication (Financial Results) – Q3F26 | |
| 11-02-2026 | Outcome of 96th Board Meeting (11.02.2026) | |
| 04-02-2026 | Intimation of 96th Board Meeting (11.02.2026) | |
| 21-01-2026 | Collaboration (HRV Global) | |
| 13-01-2026 | Report (Special Window) – Final (Dec & Jan) | |
| 07-01-2026 | Compliance Certificate (RTA) 74(5) - (Q3F26) | |
| 09-01-2026 | Reconciliation of Share Capital Audit Report (Q3F26) | |
| Closure of Trading Window | ||
| 08-12-2025 | Report (Special Window) – Nov25 | |
| 06-12-2025 | Demand Notice | |
| 25-11-2025 | New Scrip ID (HALEOSLABS) | |
| 25-11-2025 | New Logo | |
| 12-11-2025 | Newspaper Publication (Financial Results) – Q2F26 | |
| Unclaimed Dividend (F25) as on Oct 30, 2025 | ||
| 10-11-2025 | Outcome of 95th Board Meeting (10.11.2025) | |
| 11-08-2025 | Outcome of 94th Board Meeting (11.08.2025) | |
| 05-11-2025 | Report (Special Window) – Oct25 | |
| 04-11-2025 | Intimation of 95th Board Meeting (10.11.2025) | |
| Transcript – 19th AGM | ||
| 17-10-2025 | Reconciliation of Share Capital Audit Report (Q2F26) | |
| 12-10-2025 | Report (Special Window) – Sept25 | |
| 14-10-2025 | Compliance Certificate (RTA) 74(5) - (Q2F26) | |
| 08-07-2025 | Compliance Certificate (RTA) 74(5) - (Q1F26) | |
| 30-09-2025 | AGM - Outcome of AGM | |
| 01-10-2025 | AGM - Scrutinizer's Report | |
| 10-08-2022 | Update of material subsidiary | |
| 26-09-2025 | ANVISA Inspection | |
| Closure of Trading Window | ||
| 09-09-2025 | Annual Report (Weblink) | |
| 06-09-2024 | Newspaper Advertisement (AGM Notice) | |
| 06-09-2025 | AGM Notice (Sept 30, 2025) | |
| 02-07-2025 | Special Window for Re-lodgement of Transfer Requests of Physical Share | |
| 28-08-2025 | Record date (dividend) | |
| 16-07-2025 | Saksham Niveshak | |
| 21-08-2025 | Name Change of the Company | |
| 31-05-2025 | Newspaper Publication (Financial Results) | |
| 06-08-2025 | Intimation of 94th Board Meeting (11.08.2025) | |
| 23-07-2025 | Reconciliation of Share Capital Audit Report (Q1F26) | |
| 23-07-2025 | Special window for transfer of Physical shares & reminder on unclaimed dividends | |
| 16-07-2025 | Establishment Inspection Report | |
| 14-07-2025 | Investor Presentation Q4F25 | |
| 01-07-2025 | Communication to Shareholders (Reminder no. 5) | |
| Events Calendar (Postal Ballot) | ||
| Closure of Trading Window | ||
| Newspaper Publication (Financial Results) | ||
| 27-06-2025 | Annual Secretarial Compliance F25 | |
| 29-05-2025 | Outcome of 93rd Board Meeting (29.05.2025) | |
| 12-02-2025 | Reappointment Of Executive Director | |
| 28-07-2020 | Reappointment Of Auditors | |
| 22-05-2025 | intimation of 93rd Board Meeting (29.05.2025) | |
| 08-04-2022 | USFDA Inspection | |
| 05-04-2025 | Investor Complain (Q4F25) | |
| 07-04-2025 | Compliance Certificate (RTA) (Q4F25) - 74(5) | |
| 10-04-2025 | Credit Ratings (Withdrawal) | |
| 02-01-2025 | Investor Complain (Q3F25) | |
| 05-04-2025 | Encumbrance (Annual Disclosure) | |
| 05-04-2025 | Annual Confirmation (Reclassification) | |
| 04-03-2025 | Clarification (Credit Ratings) | |
| 06-03-2025 | Shareholders Queries (Weblink) | |
| 28-03-2025 | Name Change (Update) | |
| 28-03-2025 | Events Calendar (Postal Ballot) | |
| 22-02-2025 | Credit Rating | |
| 13-02-2025 | Integrated Filing (Financial) | |
| 13-02-2025 | Independent Directors Meeting | |
| 13-02-2025 | Sub-Committees Of Board (Reconstitution) | |
| 12.02.2025 | Outcome Of 92nd Board Meeting (12.02.2025) | |
| 29-05-2022 | Reappointment Of Managing Director | |
| 12-02-2025 | Appointment Of Women Independent Director | |
| 07-02-2025 | Intimation of 92nd Board Meeting (13.02.2025) | |
| 18-01-2025 | Reconciliation of Share Capital Audit Report (Q3F25) | |
| 24-01-2025 | USFDA Update (Material Subsidiary) | |
| 27-01-2025 | Notice of Postal Ballot | |
| 28-01-2025 | Newspaper Publication (Postal Ballot) | |
| 21-07-2022 | Events Calendar (Postal Ballot) | |
| 07-01-2025 | Compliance Certificate (RTA) (Q3F25) - 74(5) | |
| 30-12-2024 | Temporary withheld of Dividend | |
| 25-12-2024 | Closure of Trading Window | |
| 13-11-2024 | Outcome of 91st Board Meeting (13.11.2024) | |
| - | Unclaimed dividend for F24 as on 30.10.2024 | |
| 08-11-2024 | Intimation of 91st Board Meeting (13.11.2024) | |
| 30-09-2024 | Transcript – 18th AGM | |
| 14-10-2024 | Reconciliation of Share Capital Audit Report (Q2F25) | |
| 14-10-2024 | Compliance Certificate (RTA) (Q2F25) - 74(5) | |
| 07-10-2024 | Investor Complain (Q2F25) | |
| 08-10-2024 | Issue of Duplicate Share Certificate to K Suryanarayana | |
| 30-09-2024 | Outcome of 18th Annual General Meeting | |
| 26-09-2024 | Closure of Trading Window (September 26, 2024) | |
| 13-09-2024 | Request To Claim Fractional Entitlement Amount | |
| - | Newspaper Advertisement (AGM Notice) | |
| 06-09-2024 | AGM Notice (Sept 30, 2024) | |
| 24-08-2024 | Events Calendar (AGM) | |
| 05-09-2022 | Book Closure & Record Date | |
| 31-05-2025 | Newspaper Publication (Financial Results) – Q1F25 | |
| 09-08-2024 | Outcome of 90th Board Meeting (09.08.2024) | |
| 06-08-2024 | Intimation of 90th Board Meeting (09.08.2024) | |
| 29-06-2024 | Loss of Share Certificate | |
| 25-06-2024 | Communication to Shareholders | |
| 05-07-2024 | Investor Complain (Q1F25) | |
| 08-07-2025 | Compliance Certificate (RTA) (Q1F25) - 74(5) | |
| 22-04-2024 | Reconciliation of Share Capital Audit Report (Q4F24) | |
| 18-07-2024 | Reconciliation of Share Capital Audit Report (Q1F25) | |
| 28-03-2024 | Closure of Trading Window | |
| 29-05-2024 | Newspaper Publication (Financial Results) – Q4F24 | |
| 30-05-2024 | Annual Secretarial Compliance Report F24 | |
| 27-05-2024 | Appointment of SMP (General Manager – R&D) | |
| 27-05-2024 | Appointment of Secretarial / Cost Auditor | |
| 27-05-2024 | Outcome of 89th Board Meeting (27.04.2024) | |
| 21-05-2024 | Intimation of 89th Board Meeting (27.05.2024) | |
| 17-05-2024 | Change in Management | |
| 05-04-2023 | Encumbrance (Annual Disclosure) | |
| 05-04-2023 | Large Corporate (Not Applicable) | |
| 11-04-2024 | Compliance Certificate (RTA) FY24 - 7(3) | |
| 22-04-2024 | Compliance Certificate (PCS) F24 | |
| 10-04-2024 | Investor Complain Q4F24 | |
| 11-04-2024 | Compliance Certificate (RTA) Q4F24 - 74(5) | |
| 25-12-2024 | Closure of Trading Window | |
| 27-02-2024 | KYC Update (Communication to Shareholders) | |
| 12-02-2024 | Newspaper Publication (Financial Results) – Q3F24 | |
| 10-02-2024 | Outcome of 88th Board Meeting (10.02.2024) | |
| 10-02-2024 | Promoter Reclassification (Not Approved) | |
| 03-02-2024 | Intimation of 88th Board Meeting (10.02.2024) | |
| 17-01-2024 | RSCAR – Q3F24 | |
| 05-01-2024 | Investor Complain – Q3F24 | |
| 11-01-2024 | Compliances-Certificate under Reg. 74 (5) – Q3F24 | |
| - | Closure of Trading Window | |
| 27-12-2023 | Promoter Reclassification (Request Received) | |
| 11-11-2023 | Outcome of 87th Board Meeting (11.11.2023) | |
| - | Newspaper Publication (Financial Results) | |
| - | Unclaimed dividend for F23 as on 31.10.2023 | |
| 04-11-2023 | Intimation of 87th Board Meeting (11.11.2023) | |
| - | Transcript – 17th AGM | |
| 12-10-2023 | RSCAR - Q2F24 | |
| 05-10-2023 | Investor Complain - Q2F24 | |
| 15-04-2022 | Compliances-Certificate under Reg. 74 (5) - Q2F24 | |
| 27-09-2023 | Update On Material Subsidiary | |
| 29-09-2023 | Outcome of 17th AGM | |
| 28-09-2023 | Closure of Trading Window | |
| 07-09-2023 | Newspaper advertisement (AGM) | |
| 18-08-2023 | Credit Rating | |
| 19-08-2023 | Events Calendar (AGM) | |
| 09-08-2023 | Newspaper Publication (Financial Results) | |
| 08-08-2023 | Outcome of 86th Board Meeting (08.08.2023) | |
| 02-08-2023 | Intimation of 86th Board Meeting (08.08.2023) | |
| 05-07-2023 | Investor Complain Q1F24 | |
| 17-07-2023 | RSCAR Q1F24 | |
| 11-07-2023 | Compliance Certificate (RTA) Q1F24 - 74(5) | |
| 22-06-2023 | 20230622 Insider SAST Disclosure | |
| 28-06-2023 | Closure of Trading Window | |
| 02-06-2023 | Violation Report (Insider Trading Code) | |
| 26-05-2023 | 20230510 Insider SAST Disclosure | |
| 31-05-2023 | Code of Conduct under SEBI (PIT) Regulations, 2015 | |
| 13-02-2023 | Newspaper Publication (Financial Results) | |
| 10-08-2022 | Update on Material Subsidiary | |
| 28-07-2020 | Reappointment of Auditor(s) | |
| 29-05-2023 | Annual Secretarial Compliance FY 2022-23 | |
| 09-06-2022 | Related Party Transactions [H2-F23] | |
| 29-05-2023 | Outcome of 85th Board Meeting (29.05.2023) | |
| 22-05-2023 | Intimation of 85th Board Meeting | |
| 22-04-2024 | Compliance Certificate (PCS) F23 | |
| 12-04-2023 | RSCAR Q4F23 | |
| 10-04-2023 | Investor Complain Q4F23 | |
| 12-04-2023 | Compliance Certificate (RTA) Q4F23 - 74(5) | |
| 13-04-2023 | Compliance Certificate (RTA) FY23 - 7(3) | |
| 05-04-2023 | Large Corporate (Not Applicable) | |
| 05-04-2023 | Encumbrance (Annual Disclosure) | |
| 28-03-2023 | Trading Window Closure | |
| - | KYC Update (Communication To Shareholders) | |
| - | Newspaper Publication (Financial Results) | |
| 10-02-2023 | Outcome of 84th Board Meeting | |
| 19-06-2021 | Resignation of Director | |
| 03-02-2023 | Intimation of 84th Board Meeting | |
| 21-01-2023 | Reconciliation of Share Capital Audit Report Q3-F23 | |
| 05-01-2023 | Statement of Investor Complaints – Q3 | |
| 10-01-2022 | Compliance Certificate (RTA) – Q3 | |
| - | Closure of Trading Window | |
| 27-12-2022 | 20221226 Insider SAST Disclosure | |
| Related Party Transactions (H1 F23) | ||
| Newspaper Publication (Financial Results) | ||
| Update On Material Subsidiary | ||
| Outcome of 83rd Board Meeting | ||
| Unclaimed dividend for F22 as on 31.10.2022 | ||
| Intimation of 83rd Board Meeting | ||
| Compliance Certificate (RTA) – Q2 | ||
| Statement of Investor Complaints – Q2 | ||
| Transcript – 16th AGM | ||
| Outcome of AGM | ||
| Trading Window Closure | ||
| Update on material subsidiary | ||
| Newspaper Advertisement (AGM Notice) | ||
| AGM Notice (Sept 30, 2022) | ||
| Book Closure & Record Date | ||
| Communication To Shareholders | ||
| Events Calendar (AGM) | ||
| Newspaper Advertisement | ||
| Outcome of 82nd Board Meeting | ||
| Update on material subsidiary | ||
| Intimation of 82nd Board Meeting | ||
| Calendar Of Events (Postal Ballot) | ||
| Communication to Shareholders to update KYC details | ||
| Reconciliation of Share Capital Audit Report Q1-F23 | ||
| Compliance Certificate Q1-F23 | ||
| Investor Complain Q1-F23 | ||
| Credit Rating | ||
| Closure of Trading Window | ||
| 20220627 InsiderSAST Disclosure | ||
| 20220623 InsiderSAST Disclosure | ||
| 20220618 InsiderSAST Disclosure | ||
| Establishment Inspection Report (US FDA) | ||
| Violation Report (Suresh Babu) | ||
| Related Party Transactions For The Half Year Ended March 31, 2022 | ||
| Corporate Information | ||
| Outcome of Board Meeting | ||
| Update On Subsidiary (Change In Board) | ||
| Reappointment Of Auditor(S) | ||
| Reappointment Of Managing Director | ||
| Newspaper Publication (Financial Results) | ||
| Annual Secretarial Compliance | ||
| Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter & Year Ended March 31, 2022 | ||
| Update on issue of duplicate share certificate pursuant to our Intimation dated April 14, 2022 | ||
| Update on disinvestment in Mahi Drugs Private Limited | ||
| Compliance Certificate (Practicing Company Secretary) | ||
| Statement Of Investor Complaints For The Quarter Ended March 2022 | ||
| Compliance Certificate (RTA) | ||
| Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | ||
| Large Corporate Criteria (Not Applicable) | ||
| RSCAR – Q4F22 | ||
| Detail s of Loss of Certificate | ||
| Reclassification Of Promoters (Approved) | ||
| Clariifcation Letter for Price Movement | ||
| Completion Of USFDA Inspection | ||
| Closure of Trading Window | ||
| Disclosure For Intimation Received From Promoter Group | ||
| SAST & PT Disclosure | ||
| Reappointment of Independent Director | ||
| Outcome of Board Meeting | ||
| Newspaper Advertisement (Q3 results) | ||
| Intimation of Board Meeting | ||
| Investor Complains Q3 | ||
| Compliance Certificate – RTA – Q3 | ||
| Reconciliation of Share Capital Audit –Q3 | ||
| Outcome of Postal Ballot. | ||
| Closure of Trading Window | ||
| Notice of Postal Ballot | ||
| Newspaper Advertisement | ||
| Clarification Letter | ||
| Details of Disinvestment | ||
| Outcome of Board Meeting | ||
| Related Party Transactions H2F22 | ||
| Intimation of Board meeting scheduled to be held on November 30, 2021 | ||
| Intimation of Board Meeting Q2F22 | ||
| Outcome of Board Meeting | ||
| Resignation of Independent Director | ||
| Appointment of Independent Directors | ||
| Reconstitution of Sub-committees | ||
| Newspaper publications | ||
| Disclosure – Hari Kishore Potluri | ||
| Unclaimed dividend for F21 as on 31.10.2021 | ||
| Submission of application for reclassification | ||
| Clarification letter for price movement | ||
| RTA Compliance Certificate Q2 | ||
| Reconcile Share Capital Audit Report Q2 | ||
| Investor Complains Q2 | ||
| Transcript - 15th AGM | ||
| Outcome of AGM | ||
| Trading Window Closure | ||
| Update on Subsidiary | ||
| Newspaper Advertisement | ||
| Communication to Shareholders | ||
| Intimation of Book closure | ||
| Resignation (T Neelaveni) | ||
| Appointment (Sudeepthi) | ||
| AGM – Calendar Events | ||
| Outcome of Board Meeting (02.09.2021) | ||
| Intimation of Board Meeting (02.09.2021) | ||
| Outcome of Board Meeting | ||
| Reclassification of Promoters (Board approval) | ||
| Newspaper Advertisement | ||
| Board meeting intimation | ||
| Reclassification of promoters (request letter) | ||
| Clarification Letter – NSE | ||
| Reconcile of Share Capital Audit Report Q1 | ||
| Investor Complaints Q1 | ||
| RTA Compliance Certificate Q1 | ||
| Consolidated related party transactions H1F21 | ||
| Disclosure under PIT – IV | ||
| Clarification Letter (revised) | ||
| Disclosure under PIT III | ||
| Disclosure under PIT II | ||
| Closure of Trading Window | ||
| Disclosure pursuant to Insider Regulations | ||
| Annual Secretarial Compliance Report | ||
| Resignation of Director | ||
| Reappointment of Auditor(s) | ||
| Newspaper Advertisement | ||
| Publication of Financial Results in Newspaper | ||
| Outcome of Board Meeting | ||
| Reschedule Of Board Meeting | ||
| Board Meeing Intimation for Considering Dividend | ||
| Board Meeting - Intimation | ||
| Violation Report | ||
| RTA – Compliance certificate [Q4F21] | ||
| Complainee certificate issued by Share Transfer Agent [H2F21] | ||
| Investor Grievances Report [Q4F21] | ||
| RSCAR –Q4F21 | ||
| PCS – Compliance Certificate | ||
| Clarification - Price Movement | ||
| Closure of Trading window Q4F21 | ||
| Designated Depositary - CDSL | ||
| Annual Promoter Disclosure | ||
| Encumbrance of shares | ||
| Large Corporate Criteria not Applicable | ||
| Newspaper AD - Results | ||
| Outcome of Board meeting | ||
| Reappointment of Intendent Director | ||
| DSIR Recognition Of in-house R&D Unit. | ||
| Newspaper Advertisemnet - Board Meeting intimation | ||
| Board Meeting Intimation | ||
| RECONCILIATION OF SHARE CAPITAL AUDIT REPORT [Q3-F21] | ||
| Investor grievances report Q3 | ||
| Compliance Certificate – Q3 | ||
| SAST - PIT Disclosure | ||
| Report on Inter-se Transfer | ||
| Closure of Trading Window | ||
| Interse Transfer - Reg 10(7) | ||
| Interse Transfer - Reg 10(5) | ||
| PIT Disclosure 11.12.2020 | ||
| Disclosure Regarding Release Of Pledged Shares | ||
| PIT Disclosure 09.12.2020 | ||
| Intimation for Interse Transfer - Reg. 10(5) | ||
| Consolidated Related Party Transactions [H1-F21] | ||
| PIT Disclosure 08.12.2020 | ||
| PIT Disclosure 25.11.2020 | ||
| Newspaper advertisements for financial results | ||
| Outcome of Board Meeting | ||
| Violation under PIT Regulations | ||
| Newspaper Advertisement Board Meeting Intimation | ||
| Board Meeting Intimation | ||
| Transcript of 14th AGM | ||
| PCS Compliance Certificate | ||
| RTA Compliance Certificate | ||
| Statement of Investor Complaints For The Quarter Ended September 2020 | ||
| Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | ||
| PIT Disclosure II | ||
| PIT Disclosure III | ||
| Trading Window Closure | ||
| Transfer of shares between promoters | ||
| Voting results and Scrutinizers report | ||
| Proceedings of 14th AGM | ||
| PIT Disclosure | ||
| Calendar of Events – AGM | ||
| Newspaper advertisement – AGM | ||
| Consolidated Related Party Transaction for H2-F20 | ||
| Outcome of 72nd Board Meeting | ||
| Appointment of Director | ||
| Reappointment of Auditor(s) | ||
| Contact Details of KMP | ||
| Financial Results Newspaper Publications | ||
| Consolidated financial results – Q4/FY20 | ||
| Outcome of Board meeting held on 27.07.2020 | ||
| Annual Secreterial Compliance | ||
| Board Meeting intimation to approve financials for quarter and year ended March 31, 2020 | ||
| Reconciliation of Share Capital Audit Report Q1-F21 | ||
| Request To Shareholders To Register Email Address | ||
| Status of Investors Complain as on June 30, 2020 | ||
| RTA – Compliance Certificate for quarter ended June 30, 2020 | ||
| Initial Disclosure on Impact of Covid-19 Pandemic | ||
| Annual Disclosure of Encumbrance of Shares by Promoter | ||
| Compliances are not applicable to the Company Q4-F20 | ||
| Annual Disclosure by Promoter as per SAST Regulations | ||
| PCS Compliance Certificate H2F20 | ||
| Reconciliation of Share Capital Audit Report Q4-F20 | ||
| RTA Compliance Certificate H2F20 | ||
| RTA Certificate – 74(5) of SEBI (SP) Regulations Q4-F20 | ||
| Price Movement Clarification | ||
| Status of Investor Grievances Q4-F20 | ||
| Closure of Trading Window | ||
| Notice of Board Meeting on 14.02.2020 | ||
| Outcome of Board meeting held on 14.02.2020 | ||
| Appointment of Company Secretary | ||
| Newspaper publication | ||
| Related party transaction (half yearly) | ||
| Encumbrance by promoter | ||
| Disclosure under SEBI SAST and SEBI PIT dated March 6, 2020 | ||
| Disclosure under SEBI SAST and SEBI PIT dated Feb 22, 2020 | ||
| Resignation of Company Secretary | ||
| RTA Compliance certificate Q3 | ||
| Closure of trading window from Jan 1 to Feb 16 | ||
| Reconciliation of Share Capital Audit – Q3 | ||
| Status of Investor complain as on December 31, 2019 | ||
| Not falling under large corporate criteria as per SEBI Circular dated November 26, 2018 | ||
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2019 | ||
| Outcome of the Board Meeting held on 14.11.2019 | ||
| Reply to Stock Exchang on 10.10.2019 | ||
| AGM Proceedings | ||
| Scrutinizer Report & Voting Results | ||
| Outcome of the Board meeting held on 12.08.2019 | ||
| Notice of the Board Meeting | ||
| Trading Window closure | ||
| Related Party Disclosure | ||
| Outcome of the Board Meeting held on 29.05.2019. | ||
| Outcome of the Board Meeting held on 14th February, 2019. | ||
| Notice of Board meeting to be held on 14th February, 2019. | ||
| Outcome of the Board Meeting held on 13th November, 2018. | ||
| Voting Results and Scrutinizers Report | ||
| AGM Notice & Book closure | ||
| Outcome of the Board Meeting-30.07.2018 | ||
| Outcome of Board Meeting held on 28.05.2018 | ||
| USFDA INSPECTION - 05.04.2018 | ||
| Notice of Board Meeting to be held on 05.02.2018 | ||
| Notice of Board Meeting to be held on 13.12.2017 | ||
| Notice of Board Meeting to be held on 13.09.2017 |
Registered Office / Corporate Office
Plot No. 19-III, Road No. 71, Opp. Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad – 500 096, Telangana, India.
Contact Us
Email: info@haleoslabs.com
Tel: +91-40-66288888
© 2026 Haleos Labs Limited. All Rights Reserved